RESPIRATORY INFECTION

Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)

J W M Chan¹, C K Ng¹, Y H Chan¹, T Y W Mok² W H O¹, S Lee¹, S Y Y Chu¹, W L Law¹, M P Lee¹, P C K Li¹

¹ Department of Medicine, Queen Elizabeth Hospital, Hong Kong SAR, China
² Respiratory Medical Department, Kowloon Hospital, Hong Kong SAR, China

Correspondence to:
Correspondence to:
Dr J W M Chan, Department of Medicine, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong;
johnnychan{at}excite.com

Background: Severe acute respiratory syndrome (SARS) was diagnosed in Hong Kong in over 1700 patients between March and early June 2003.

Methods: 115 patients diagnosed with SARS were admitted to Queen Elizabeth Hospital, a large regional hospital in Hong Kong, from March 2003, of whom 100 were either discharged or were dead at 31 May. The patients were prospectively studied after admission to assess their short term outcomes and the risk factors associated with adverse outcomes, defined as death or the need for mechanical ventilation

Results: At the time of writing 18 patients had died, with a crude mortality rate of 15.7% and a 21 day mortality of 10% (standard error 3%). Thirty nine patients (34%) were admitted to the intensive care unit, 30 of whom (26%) required mechanical ventilation. Multivariate analysis showed that age above 60 (hazards ratio (HR) 3.5, 95% CI 1.2 to 10.2; p=0.02), presence of diabetes mellitus or heart disease (HR 9.1, 95% CI 2.8 to 29.1; p<0.001), and the presence of other comorbid conditions (HR 5.2, 95% CI 1.4 to 19.7; p=0.01) were independently associated with mortality. However, only the presence of diabetes mellitus and/or cardiac disease (HR 7.3, 95% CI 3.1 to 17.4; p<0.001) was associated with adverse outcomes as a whole.

Conclusion: SARS is a new disease entity that carries significant morbidity and mortality. Specific clinical and laboratory parameters predicting unfavourable outcomes have been identified.

Keywords: severe acute respiratory syndrome (SARS); risk factors; mortality

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Hsu, C.-H., Hwang, K.-C., Chao, C.-L., Chang, S. G. N., Ho, M.-S., Lin, J.-G., Chang, H.-H., Kao, S.-T., Chen, Y.-M., Chou, P. (2008). An Evaluation of the Additive Effect of Natural Herbal Medicine on SARS or SARS-like Infectious Diseases in 2003: A Randomized, Double-blind, and Controlled Pilot Study. Evid Based Complement Alternat Med 5: 355-362 [Abstract] [Full Text]  
• Gu, J., Korteweg, C. (2007). Pathology and Pathogenesis of Severe Acute Respiratory Syndrome. Am. J. Pathol. 170: 1136-1147 [Abstract] [Full Text]  
• Hui, D. S., Wong, K. T., Ko, F. W., Tam, L. S., Chan, D. P., Woo, J., Sung, J. J.Y. (2005). The 1-Year Impact of Severe Acute Respiratory Syndrome on Pulmonary Function, Exercise Capacity, and Quality of Life in a Cohort of Survivors. Chest 128: 2247-2261 [Abstract] [Full Text]  
• Ghani, A. C., Donnelly, C. A., Cox, D. R., Griffin, J. T., Fraser, C., Lam, T. H., Ho, L. M., Chan, W. S., Anderson, R. M., Hedley, A. J., Leung, G. M. (2005). Methods for Estimating the Case Fatality Ratio for a Novel, Emerging Infectious Disease. Am J Epidemiol 162: 479-486 [Abstract] [Full Text]  
• Chiou, H.-E., Liu, C.-L., Buttrey, M. J., Kuo, H.-P., Liu, H.-W., Kuo, H.-T., Lu, Y.-T. (2005). Adverse Effects of Ribavirin and Outcome in Severe Acute Respiratory Syndrome: Experience in Two Medical Centers. Chest 128: 263-272 [Abstract] [Full Text]  
• NISHIURA, H., KURATSUJI, T., QUY, T., PHI, N. C., VAN BAN, V., HA, L. D., LONG, H. T., YANAI, H., KEICHO, N., KIRIKAE, T., SASAZUKI, T., ANDERSON, R. M. (2005). RAPID AWARENESS AND TRANSMISSION OF SEVERE ACUTE RESPIRATORY SYNDROME IN HANOI FRENCH HOSPITAL, VIETNAM. Am J Trop Med Hyg 73: 17-25 [Abstract] [Full Text]  
• Roberts, A., Paddock, C., Vogel, L., Butler, E., Zaki, S., Subbarao, K. (2005). Aged BALB/c Mice as a Model for Increased Severity of Severe Acute Respiratory Syndrome in Elderly Humans. J. Virol. 79: 5833-5838 [Abstract] [Full Text]  
• Hui, D S, Joynt, G M, Wong, K T, Gomersall, C D, Li, T S, Antonio, G, Ko, F W, Chan, M C, Chan, D P, Tong, M W, Rainer, T H, Ahuja, A T, Cockram, C S, Sung, J J Y (2005). Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax 60: 401-409 [Abstract] [Full Text]  
• Antonio, G. E., Wong, K. T., Tsui, E. L. H., Chan, D. P. N., Hui, D. S. C., Ng, A. W. H., Shing, K. K., Yuen, E. H. Y., Chan, J. C. K., Ahuja, A. T. (2005). Chest Radiograph Scores as Potential Prognostic Indicators in Severe Acute Respiratory Syndrome (SARS). Am. J. Roentgenol. 184: 734-741 [Abstract] [Full Text]  
• Sheth, A., Romanelli, F. (2005). Severe Acute Respiratory Syndrome: Emergence of a New Pandemic. Journal of Pharmacy Practice 18: 63-70 [Abstract]  
• Yip, T. T.C., Chan, J. W.M., Cho, W. C.S., Yip, T.-T., Wang, Z., Kwan, T.-L., Law, S. C.K., Tsang, D. N.C., Chan, J. K.C., Lee, K.-C., Cheng, W.-W., Ma, V. W.S., Yip, C., Lim, C. K.P., Ngan, R. K.C., Au, J. S.K., Chan, A., Lim, W. W.L., and Queen Elizabeth Hospital/Hong Kong Government, (2005). Protein Chip Array Profiling Analysis in Patients with Severe Acute Respiratory Syndrome Identified Serum Amyloid A Protein as a Biomarker Potentially Useful in Monitoring the Extent of Pneumonia. Clin. Chem. 51: 47-55 [Abstract] [Full Text]  
• Chu, C.-M., Poon, L. L.M., Cheng, V. C.C., Chan, K.-S., Hung, I. F.N., Wong, M. M.L., Chan, K.-H., Leung, W.-S., Tang, B. S.F., Chan, V. L., Ng, W.-L., Sim, T.-C., Ng, P.-W., Law, K.-I., Tse, D. M.W., Peiris, J. S.M., Yuen, K.-Y. (2004). Initial viral load and the outcomes of SARS. CMAJ 171: 1349-1352 [Abstract] [Full Text]  
• Ng, C K, Chan, J W M, Kwan, T L, To, T S, Chan, Y H, Ng, F Y Y, Mok, T Y W (2004). Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivors. Thorax 59: 889-891 [Abstract] [Full Text]  
• Ko, S.-F., Lee, T.-Y., Huang, C.-C., Cheng, Y.-F., Ng, S.-H., Kuo, Y.-L., Lin, M.-C., Liu, J.-W., Yang, K. D., Chen, M.-C., Chen, C.-L. (2004). Severe Acute Respiratory Syndrome: Prognostic Implications of Chest Radiographic Findings in 52 Patients. Radiology 233: 173-181 [Abstract] [Full Text]  
• Hui, D. S.C., Sung, J. J.Y. (2004). Treatment of Severe Acute Respiratory Syndrome. Chest 126: 670-674 [Full Text]  
• Yu, W C, Hui, D S C, Chan-Yeung, M (2004). Antiviral agents and corticosteroids in the treatment of severe acute respiratory syndrome (SARS). Thorax 59: 643-645 [Full Text]  
• Wu, C.-Y., Jan, J.-T., Ma, S.-H., Kuo, C.-J., Juan, H.-F., Cheng, Y.-S. E., Hsu, H.-H., Huang, H.-C., Wu, D., Brik, A., Liang, F.-S., Liu, R.-S., Fang, J.-M., Chen, S.-T., Liang, P.-H., Wong, C.-H. (2004). Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc. Natl. Acad. Sci. USA 101: 10012-10017 [Abstract] [Full Text]  
• Hui, D S C, Chan, M C H, Wu, A K, Ng, P C (2004). Severe acute respiratory syndrome (SARS): epidemiology and clinical features. Postgrad. Med. J. 80: 373-381 [Abstract] [Full Text]  
• Chu, C M, Cheng, V C C, Hung, I F N, Wong, M M L, Chan, K H, Chan, K S, Kao, R Y T, Poon, L L M, Wong, C L P, Guan, Y, Peiris, J S M, Yuen, K Y (2004). Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 59: 252-256 [Abstract] [Full Text]  
• Peiris, J. S.M., Yuen, K. Y., Osterhaus, A. D.M.E., Stohr, K. (2003). The Severe Acute Respiratory Syndrome. NEJM 349: 2431-2441 [Full Text]  
• Bernard, G. R. (2003). Corticosteroids: The "Terminator" of All Untreatable Serious Pulmonary Illness. Am. J. Respir. Crit. Care Med. 168: 1409-1410 [Full Text]  
• Groneberg, D.A., Zhang, L., Welte, T., Zabel, P., Chung, K.F. (2003). Severe acute respiratory syndrome: global initiatives for disease diagnosis. QJM 96: 845-852 [Abstract] [Full Text]